See the DrugPatentWatch profile for ozempic
Ozempic (semaglutide) is a medication used to treat type 2 diabetes and obesity. However, it's essential to consider certain medical conditions and factors before starting treatment with Ozempic. Individuals with the following medical history may not be suitable candidates for Ozempic treatment:
1. History of pancreatitis: Ozempic has been linked to an increased risk of pancreatitis, a serious condition that can cause inflammation of the pancreas. Individuals with a history of pancreatitis may be at a higher risk of developing pancreatitis again while taking Ozempic [1].
2. History of thyroid C-cell tumors: Ozempic has been shown to increase the risk of thyroid C-cell tumors, including medullary thyroid carcinoma [2]. Individuals with a history of thyroid C-cell tumors or a family history of these tumors may be at a higher risk of developing new tumors while taking Ozempic.
3. History of multiple endocrine neoplasia syndrome type 2 (MEN 2): MEN 2 is a rare genetic disorder that increases the risk of thyroid C-cell tumors. Individuals with a history of MEN 2 may be at a higher risk of developing thyroid C-cell tumors while taking Ozempic [3].
4. Severe kidney impairment: Ozempic is not recommended for individuals with severe kidney impairment (eGFR < 30 mL/min) due to the risk of worsening kidney function [4].
5. History of hypersensitivity to semaglutide or other GLP-1 receptor agonists: Individuals with a history of hypersensitivity to semaglutide or other GLP-1 receptor agonists may experience an allergic reaction or anaphylaxis while taking Ozempic [5].
It's essential to discuss any medical history or concerns with a healthcare provider before starting treatment with Ozempic. They can help determine if Ozempic is appropriate for an individual based on their medical history and other factors.
Sources:
[1] Novo Nordisk. (2020). Ozempic Prescribing Information.
[2] FDA. (2020). Ozempic (semaglutide) Injection.
[3] DrugPatentWatch.com. (2020). Semaglutide (Ozempic) Patent Expiration.
[4] Novo Nordisk. (2020). Ozempic Prescribing Information.
[5] Novo Nordisk. (2020). Ozempic Prescribing Information.
Note: The information provided is based on the available data and should not be considered as medical advice. It's essential to consult with a healthcare provider for personalized guidance.